Atlas Trials

Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement

Clinical trial NCT02765854 · COMPLETED

Trial details

NCT number
NCT02765854
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Start date
2016-09-01
Primary completion
2023-05-23
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.